Open Orphan plc

PINK:OPORF USA Biotechnology
Market Cap
$164.93 Million
Market Cap Rank
#16920 Global
#6471 in USA
Share Price
$0.24
Change (1 day)
+0.00%
52-Week Range
$0.24 - $0.24
All Time High
$0.52
About

hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including assay development, cell based assays, molecular, immunology, virology, clinical field trail logistics, and biomarker an… Read more

Open Orphan plc (OPORF) - Total Assets

Latest total assets as of June 2025: $85.67 Million USD

Based on the latest financial reports, Open Orphan plc (OPORF) holds total assets worth $85.67 Million USD as of June 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Open Orphan plc - Total Assets Trend (2011–2024)

This chart illustrates how Open Orphan plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Open Orphan plc - Asset Composition Analysis

Current Asset Composition (December 2024)

Open Orphan plc's total assets of $85.67 Million consist of 67.8% current assets and 32.3% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 49.7%
Accounts Receivable $13.96 Million 15.7%
Inventory $804.00K 0.9%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $101.00K 0.1%
Goodwill $5.60 Million 6.3%

Asset Composition Trend (2011–2024)

This chart illustrates how Open Orphan plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Open Orphan plc's current assets represent 67.8% of total assets in 2024, an increase from 55.6% in 2011.
  • Cash Position: Cash and equivalents constituted 49.7% of total assets in 2024, up from 5.4% in 2011.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 2011.
  • Asset Diversification: The largest asset category is accounts receivable at 15.7% of total assets.

Open Orphan plc Competitors by Total Assets

Key competitors of Open Orphan plc based on total assets are shown below.

Company Country Total Assets
MedPacto Inc
KQ:235980
Korea ₩51.58 Billion
2H0
F:2H0
Germany €15.27 Million
Shenzhen CAU Technology Co Ltd
SHE:000004
China CN¥260.55 Million
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
China CN¥9.58 Billion
Nanhua Bio Medicine Co Ltd
SHE:000504
China CN¥841.96 Million
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
China CN¥509.14 Million
Chengzhi Shareholding Co Ltd
SHE:000990
China CN¥27.52 Billion
Hualan Biological EngineeringInc
SHE:002007
China CN¥16.27 Billion

Open Orphan plc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.36 - 1.61

Strong asset utilization - Open Orphan plc generates 0.71x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -62.28% - 19.36%

Excellent ROA - For every $100 in assets, Open Orphan plc generates $ 11.98 in net profit.

Open Orphan plc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.60 1.61 2.72
Quick Ratio 1.53 1.60 2.57
Cash Ratio 0.00 0.00 0.00
Working Capital $15.86 Million $ 21.80 Million $ 11.54 Million

Open Orphan plc - Advanced Valuation Insights

This section examines the relationship between Open Orphan plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.00
Latest Market Cap to Assets Ratio 1.52
Asset Growth Rate (YoY) 6.8%
Total Assets $88.89 Million
Market Capitalization $135.41 Million USD

Valuation Analysis

Above Book Valuation: The market values Open Orphan plc's assets above their book value (1.52 x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Open Orphan plc's assets grew by 6.8% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Open Orphan plc (2011–2024)

The table below shows the annual total assets of Open Orphan plc from 2011 to 2024.

Year Total Assets Change
2024-12-31 $88.89 Million +6.81%
2023-12-31 $83.23 Million +61.99%
2022-12-31 $51.38 Million +21.54%
2021-12-31 $42.27 Million -12.92%
2020-12-31 $48.55 Million +434.70%
2019-12-31 $9.08 Million +16.32%
2018-12-31 $7.81 Million -28.01%
2017-12-31 $10.84 Million -13.56%
2016-12-31 $12.54 Million +11.59%
2015-12-31 $11.24 Million +140.57%
2014-12-31 $4.67 Million +135.21%
2013-12-31 $1.99 Million -44.80%
2012-12-31 $3.60 Million +106.64%
2011-12-31 $1.74 Million --